v3.26.3
Document and Entity Information
 12 Months Ended
Dec. 31, 2025
shares
Document Information  
Document Type 40-F/A
Document Registration Statement false
Document Annual Report true
Document Period End Date Dec. 31, 2025
Entity File Number 001-43048
Entity Registrant Name NERVGEN PHARMA CORP.
Entity Incorporation, State or Country Code A1
Entity Primary SIC Number 2834
Entity Tax Identification Number 98-1738183
Entity Address, Address Line One 1200 Brickell Avenue, Suite 1950
Entity Address, Adress Line Two #IP 1346
Entity Address, City or Town Miami
Entity Address State Or Province FL
Entity Address, Postal Zip Code 33131
City Area Code 778
Local Phone Number 731-1711
Title of 12(b) Security Common Shares, no par value
Trading Symbol NGEN
Security Exchange Name NASDAQ
Annual Information Form true
Audited Annual Financial Statements true
Entity Common Stock, Shares Outstanding 79,649,257
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Emerging Growth Company true
Entity Ex Transition Period false
ICFR Auditor Attestation Flag false
Document Financial Statement Error Correction [Flag] true
Document Financial Statement Restatement Recovery Analysis [Flag] false
Auditor Name KPMG LLP
Auditor Location Vancouver, Canada
Auditor Firm ID 85
Entity Central Index Key 0001751912
Current Fiscal Year End Date --12-31
Document Fiscal Year Focus 2025
Document Fiscal Period Focus FY
Amendment Flag true
Amendment Description Amendment No. 1
Business Contact  
Document Information  
Contact Personnel Name Cogency Global Inc.
Entity Address, Address Line One 122 E. 42nd Street, 18th Floor
Entity Address, City or Town New York
Entity Address State Or Province NY
Entity Address, Postal Zip Code 10168
City Area Code 800
Local Phone Number 221-0102